The Latest Breaking News from Novartis

Scotland is to become the first part of the UK to routinely screen newborn babies for a 'devastating' rare medical condition ...

From early 2026 it is expected babies born in Scotland will be routinely tested for Spinal Muscular Atrophy.

Leqvio saw users achieve their target cholesterol levels faster than existing treatments

Cholesterol is a fatty substance made by the liver and found in some foods.

Novartis AG (NYSE:NVS) released topline results on Tuesday from the VAYHIT2 Phase 3 trial evaluating ianalumab plus eltrombopag in patients with primary immune thrombocytopenia (ITP) previously treated with corticosteroids.

U.S. trade partners are reacting to President Donald Trump’s executive order that would introduce new tariffs on many of them in seven days

The first malaria treatment for babies and very young children of 2 months up to 5 years was approved for use by Swiss agency for therapeutic products, Swissmedic, in early July 2025. Until now, babies and very young children have been treated with medicines formulated for older children.

Editor’s Note: The title of the story has been corrected to reflect that the outlook was raised, instead of the erroneous “outlook cut” mentioned in the original title.

IN FULL

The newly approved medication is a lower-dose version of a tablet previously approved for other age groups

Several African countries where malaria is widespread are expected to swiftly approve the new medicine following Swissmedic’s decision.